Evaluation of treatment response with PERCIST in follicular lymphoma receiving rituximab single-agent immunotherapy

被引：0
|
作者：
Tatsumi, Mitsuaki [1 ]
Watabe, Tadashi [1 ]
Kato, Hiroki [1 ]
Imaizumi, Masao [1 ]
Shimosegawa, Eku [1 ]
Hatazawa, Jun [1 ]
机构：
[1] Osaka Univ, Grad Sch Med, Suita, Osaka, Japan
来源：
JOURNAL OF NUCLEAR MEDICINE | 2012年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1364
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Single-Agent Rituximab and Ultra-Low-Dose Adaptive Radiotherapy for the Treatment of Indolent Non-Hodgkin Lymphoma
    Jackson, Meredith
    All, Sean
    Brocklehurst, Samantha
    Desai, Neil B.
    Shah, Jennifer L.
    Rizvi, Syed M.
    Awan, Farrukh T.
    Geethakumari, Praveen Ramakrishnan
    Kumar, Kiran A.
    BLOOD, 2021, 138
  • [22] Single-agent thalidomide induces response in T-cell lymphoma
    Damaj, G
    Bouabdallah, R
    Vey, N
    Bilger, K
    Mohty, M
    Gastaut, JA
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2005, 74 (02) : 169 - 171
  • [23] Sequential single-agent obatoclax mesylate (GX15-070MS) followed by combination with rituximab in patients with previously untreated follicular lymphoma
    Goy, Andre
    Berger, Mark
    Ford, Peggy
    Feldman, Tatyana
    Mato, Anthony
    Bejot, Colleen
    Fung, Henry C.
    LEUKEMIA & LYMPHOMA, 2014, 55 (12) : 2932 - 2934
  • [24] Combined Modality Low-Dose Radiation Therapy (2 Gy x 2) and Single-Agent Rituximab Immunotherapy in the Treatment of Indolent Non-Hodgkin Lymphoma
    Brocklehurst, Samantha
    Desai, Neil
    Shah, Jennifer L.
    Rizvi, Syed
    Geethakumari, Praveen Ramakrishnan
    Kumar, Kiran A.
    BLOOD, 2019, 134
  • [25] Successful Treatment of Multiply Relapsed Lymphoma With Rituximab as a Single Agent
    Alasaad, Tariq
    Barr, Ronald
    PEDIATRIC BLOOD & CANCER, 2010, 55 (02) : 356 - 358
  • [26] SINGLE-AGENT LENALIDOMIDE FOR THE TREATMENT OF RELAPSED OR REFRACTORY AGGRESSIVE LYMPHOMA PATIENTS
    Puccini, B.
    Chitarrelli, I.
    Antognoli, G.
    Fabbri, A.
    Rigacci, L.
    Lenoci, M. P.
    Lauria, F.
    Bosi, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 288 - 288
  • [27] LOCALIZED FOLLICULAR LYMPHOMA TREATMENT WITH RITUXIMAB AND RADIOTEHRAPY
    Puccini, B.
    Rigacci, L.
    Fabbri, A.
    Kovalchuk, S.
    Mannelli, L.
    Cencini, E.
    Lancia, F.
    Benelli, G.
    Simontacchi, G.
    Bocchia, M.
    Bosi, A.
    HAEMATOLOGICA, 2015, 100 : 148 - 148
  • [28] Predictive Factors of Response and Survival of Lenalidomide and Rituximab As Initial Treatment of Follicular Lymphoma
    Strati, Paolo
    Johnson, Ralph J.
    Forbes, Sheryl G.
    Nastoupil, Loretta J.
    Samaniego, Felipe
    Davis, Eric
    Green, Michael R.
    Fayad, Luis
    Hagemeister, F. B.
    Westin, Jason R.
    Wang, Michael L.
    Neelapu, Sattva S.
    Fowler, Nathan H.
    BLOOD, 2019, 134
  • [29] Does the pattern of failure impact the use of single-agent 131I-tositumomab for follicular lymphoma?
    Hamstra, D. A.
    Gross, B. H.
    Francis, I. R.
    Estes, J.
    Wahl, R. L.
    Kaminski, M. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S506 - S506
  • [30] RITUXIMAB MAINTENANCE IN FOLLICULAR LYMPHOMA: SINGLE CENTER EXPERIENCE
    Uysal, A.
    Patir, P.
    Soyer, N. Akad
    Sahin, F.
    Vural, F.
    Tobu, M.
    Saydam, G.
    LEUKEMIA RESEARCH, 2016, 49 : S30 - S30
12345